James B. Breitmeyer - Apr 13, 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Executive Officer, Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Apr 13, 2023
Transactions value $
$43,930
Form type
4
Date filed
4/17/2023, 06:00 AM
Previous filing
Feb 24, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $29K +100K +214.85% $0.29 147K Apr 13, 2023 By Family Trust
transaction ONCT Common Stock Purchase $14.3K +47.8K +32.58% $0.30 194K Apr 14, 2023 By Family Trust
transaction ONCT Common Stock Purchase $653 +2.25K +1.16% $0.29 197K Apr 14, 2023 By Family Trust
holding ONCT Common Stock 542K Apr 13, 2023 Direct
holding ONCT Common Stock 23.9K Apr 13, 2023 By Spouse
holding ONCT Common Stock 733 Apr 13, 2023 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.